Porcine Vaccines Market

Porcine Vaccines Market (Disease Indication - Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCVAD); End use - Veterinary Hospitals and Hog Production Farms; Technology - Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL42440
  • Published On : Apr 2018
  • No. of Pages : 240
  • Category : Pharmaceutical

Chapter 1.Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2.Assumptions and Research Methodology

Chapter 3.Executive Summary : Global Porcine Vaccines Market

Chapter 4.Market Overview
4.1. Introduction
       4.1.1. Definition
       4.1.2. Market Evolution / Developments
4.2.  Overview
4.3. Market Dynamics
       4.3.1. Drivers
       4.3.2. Restraints
       4.3.3. Opportunities
4.4. Global Porcine Vaccines Market Analysis and Forecast, 2015–2025
       4.4.1. Market Revenue Projection (US$ Mn)
4.5. Porter’s Five Forces Analysis
4.6. Market Outlook
4.7.Regulatory Scenario Assessment
       4.7.1. North America
       4.7.2. Europe
       4.7.3. Asia Pacific
4.8.Disease Indication Comparison, by Region
       4.8.1. North America
       4.8.2. Europe 
       4.8.3. Asia Pacific
       4.8.4. Latin America
       4.8.5. Middle East & Africa
4.9.Swine Production Level, by Region/State
       4.9.1. North America
       4.9.2. Europe 
       4.9.3. Asia Pacific
       4.9.4. Latin America
4.10.Product Launches and Innovations
4.11. Recent Market Activities
4.12.Introduction of New Types of Vaccines
4.13. Snapshot of Market Trends and Issues

Chapter 5.Global Porcine Vaccines Market Analysis and Forecast, by End-user   
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast by End-user, 2015–2025
       5.3.1. Inactivated Vaccines
       5.3.2. Live Attenuated Vaccines
       5.3.3. Toxoid Vaccines
       5.3.4. Recombinant Vaccines
       5.3.5. Conjugate Vaccines
       5.3.6. DNA Vaccines
5.4. Market Attractiveness, by End-user   

Chapter 6.Global Porcine Vaccines Market Analysis and Forecast, by Disease Indication 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Disease Indication, 2015–2025
       6.3.1. Diarrhea 
       6.3.2. Swine Influenza 
       6.3.3. Arthritis
       6.3.4. Bordetella Rhinitis 
       6.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
       6.3.6. Porcine Circovirus Associated Disease (PCVAD)
       6.3.7. Others
6.4. Market Attractiveness, by Disease Indication 

Chapter 7.Global Porcine Vaccines Market Analysis and Forecast, by End-user   
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2015–2025
       7.3.1. Veterinary Hospitals
       7.3.2. Hog Production Farms
7.4. Market Attractiveness, by End-user   

Chapter 8.Global Porcine Vaccines Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
       8.2.1. North America 
       8.2.2. Europe 
       8.2.3. Asia Pacific 
       8.2.4. Latin America 
       8.2.5. Middle East & Africa 
8.3. Market Attractiveness, by Country/Region 

Chapter 9.North America Porcine Vaccines Market Analysis and Forecast
9.1. Introduction
       9.1.1. Key Findings
9.2. Market Value Forecast, by End-user, 2015–2025
       9.2.1. Inactivated Vaccines
       9.2.2. Live Attenuated Vaccines
       9.2.3. Toxoid Vaccines
       9.2.4. Recombinant Vaccines
       9.2.5. Conjugate Vaccines
       9.2.6. DNA Vaccines
9.3. Market Value Forecast, by Disease Indication, 2015–2025
       9.3.1. Diarrhea 
       9.3.2. Swine Influenza 
       9.3.3. Arthritis
       9.3.4. Bordetella Rhinitis 
       9.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
       9.3.6. Porcine Circovirus Associated Disease (PCVAD)
       9.3.7. Others
9.4. Market Value Forecast, by End-user, 2015–2025
       9.4.1. Veterinary Hospitals
       9.4.2. Hog Production Farms
9.5. Market Value Forecast, by Country, 2015–2025
       9.5.1. U.S.
       9.5.2. Canada
9.6. Market Attractiveness Analysis 
       9.6.1. By End-user   
       9.6.2. By Disease Indication 
       9.6.3. By End-user   
       9.6.4. By Country

Chapter 10.Europe Porcine Vaccines Market Analysis and Forecast
10.1.Introduction
       10.1.1. Key Findings
10.2.Market Value Forecast, by End-user, 2015–2025
       10.2.1. Inactivated Vaccines
       10.2.2. Live Attenuated Vaccines
       10.2.3. Toxoid Vaccines
       10.2.4. Recombinant Vaccines
       10.2.5. Conjugate Vaccines
       10.2.6. DNA Vaccines
10.3.Market Value Forecast, by Disease Indication, 2015–2025
       10.3.1. Diarrhea 
       10.3.2. Swine Influenza 
       10.3.3. Arthritis
       10.3.4. Bordetella Rhinitis 
       10.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
       10.3.6. Porcine Circovirus Associated Disease (PCVAD)
       10.3.7. Others
10.4.Market Value Forecast, by End-user, 2015–2025
       10.4.1. Veterinary Hospitals
       10.4.2. Hog Production Farms
10.5.Market Value Forecast, by Country/Sub-region, 2015–2025
       10.5.1. Germany
       10.5.2. U.K.
       10.5.3. France
       10.5.4. Spain
       10.5.5. Italy
       10.5.6. Russia
       10.5.7. Rest of Europe
10.6.Market Attractiveness Analysis 
       10.6.1. By End-user   
       10.6.2. By Disease Indication 
       10.6.3. By End-user   
       10.6.4. By Country/Sub-region

Chapter 11.Asia Pacific Porcine Vaccines Market Analysis and Forecast
11.1.Introduction
       11.1.1. Key Findings
11.2.Market Value Forecast, by End-user, 2015–2025
       11.2.1. Inactivated Vaccines
       11.2.2. Live Attenuated Vaccines
       11.2.3. Toxoid Vaccines
       11.2.4. Recombinant Vaccines
       11.2.5. Conjugate Vaccines
       11.2.6. DNA Vaccines
11.3.Market Value Forecast, by Disease Indication, 2015–2025
       11.3.1. Diarrhea 
       11.3.2. Swine Influenza 
       11.3.3. Arthritis
       11.3.4. Bordetella Rhinitis 
       11.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
       11.3.6. Porcine Circovirus Associated Disease (PCVAD)
       11.3.7. Others
11.4.Market Value Forecast, by End-user, 2015–2025
       11.4.1. Veterinary Hospitals
       11.4.2. Hog Production Farms
11.5.Market Value Forecast, by Country/Sub-region, 2015–2025
       11.5.1. China
       11.5.2. Japan
       11.5.3. India
       11.5.4. Australia & New Zealand
       11.5.5. Rest of Asia Pacific
11.6.Market Attractiveness Analysis 
       11.6.1. By End-user   
       11.6.2. By Disease Indication
       11.6.3. By End-user   
       11.6.4. By Country/Sub-region

Chapter 12.Latin America Porcine Vaccines Market Analysis and Forecast
12.1.Introduction
       12.1.1. Key Findings
12.2.Market Value Forecast, by End-user, 2015–2025
       12.2.1. Inactivated Vaccines
       12.2.2. Live Attenuated Vaccines
       12.2.3. Toxoid Vaccines
       12.2.4. Recombinant Vaccines
       12.2.5. Conjugate Vaccines
       12.2.6. DNA Vaccines
12.3.Market Value Forecast, by Disease Indication, 2015–2025
       12.3.1. Diarrhea 
       12.3.2. Swine Influenza 
       12.3.3. Arthritis
       12.3.4. Bordetella Rhinitis 
       12.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
       12.3.6. Porcine Circovirus Associated Disease (PCVAD)
       12.3.7. Others
12.4.Market Value Forecast, by End-user, 2015–2025
       12.4.1. Veterinary Hospitals
       12.4.2. Hog Production Farms
12.5.Market Value Forecast, by Country/Sub-region, 2015–2025
       12.5.1. Brazil
       12.5.2. Mexico
       12.5.3. Rest of Latin America
12.6.Market Attractiveness Analysis 
       12.6.1. By End-user   
       12.6.2. By Disease Indication 
       12.6.3. By End-user   
       12.6.4. By Country/Sub-region

Chapter 13.Middle East & Africa Porcine Vaccines Market Analysis and Forecast
13.1.Introduction
       13.1.1. Key Findings
13.2.Market Value Forecast, by End-user, 2015–2025
       13.2.1. Inactivated Vaccines
       13.2.2. Live Attenuated Vaccines
       13.2.3. Toxoid Vaccines
       13.2.4. Recombinant Vaccines
       13.2.5. Conjugate Vaccines
       13.2.6. DNA Vaccines
13.3.Market Value Forecast, by Disease Indication, 2015–2025
       13.3.1. Diarrhea 
       13.3.2. Swine Influenza 
       13.3.3. Arthritis
       13.3.4. Bordetella Rhinitis 
       13.3.5. Porcine Reproductive and Respiratory Syndrome (PRRS) 
       13.3.6. Porcine Circovirus Associated Disease (PCVAD)
       13.3.7. Others
13.4.Market Value Forecast, by End-user, 2015–2025
       13.4.1. Veterinary Hospitals
       13.4.2. Hog Production Farms
13.5.Market Value Forecast, by Country/Sub-region, 2015–2025
       13.5.1. South Africa
       13.5.2. Rest of Middle East & Africa
13.6.Market Attractiveness Analysis 
       13.6.1. By End-user   
       13.6.2. By Disease Indication 
       13.6.3. By End-user   
       13.6.4. By Country/Sub-region

Chapter 14.Competition Landscape
14.1.Market Player – Competition Matrix (by Tier and Size of companies)
14.2.Market Share Analysis, by Company (2016)
       14.2.1. Bayer AG
                14.2.1.1. Overview
                14.2.1.2. Financials
                14.2.1.3. Recent Developments
                14.2.1.4. Strategy
       14.2.2. Bimeda Animal Health 
                14.2.2.1. Overview
                14.2.2.2. Financials
                14.2.2.3. Recent Developments
                14.2.2.4. Strategy
       14.2.2. Boehringer Ingelheim GmbH 
                14.2.3.1. Overview
                14.2.3.2. Financials
                14.2.3.3. Recent Developments
                14.2.3.4. Strategy
       14.2.4. Ceva Santé Animale
                14.2.4.1. Overview
                14.2.4.2. Financials
                14.2.4.3. Recent Developments
                14.2.4.4. Strategy 
       14.2.5. Elanco (Eli Lilly and Company)
                14.2.5.1. Overview
                14.2.5.2. Financials
                14.2.5.3. Recent Developments
                14.2.5.4. Strategy
       14.2.6. Merck & Co., Inc.
                14.2.6.1. Overview
                14.2.6.2. Financials
                14.2.6.3. Recent Developments
                14.2.6.4. Strategy 
       14.2.7. Vetoquinol
                14.2.7.1. Overview
                14.2.7.2. Financials
                14.2.7.3. Recent Developments
                14.2.7.4. Strategy
       14.2.8. Zoetis, Inc.
                14.2.8.1. Overview
                14.2.8.2. Financials
                14.2.8.3. Recent Developments
                14.2.8.4. Strategy
       14.2.9. Others

List of Tables

Table 01: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 02: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 03: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 04: Global Porcine Vaccines Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 07: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 08: North America Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 09: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 10: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 11: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 12: Europe Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 13: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 14: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 15: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 16: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 17: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 18: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 19: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 20: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 21: Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 22: Middle East & Africa  Porcine Vaccines Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 23: Middle East & Africa  Porcine Vaccines Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
Table 24: Middle East & Africa  Porcine Vaccines Market Size (US$ Mn) Forecast, by End-user, 2015–2025

List of Figures

FIG 01: Global Porcine Vaccines Market Size (US$ Mn) Forecast, 2015–2025
FIG 02: Global Porcine Vaccines Market Value Share, by Technology (2016)
FIG 03: Global Porcine Vaccines Market Value Share, by Region (2016)
FIG 04: Global Porcine Vaccines Market Value Share, by End-user (2016)
FIG 05: Global Porcine Vaccines Market Value Share, by Disease Indication (2016)
FIG 06: Global Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 07: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inactivated Vaccines, 2015–2025
FIG 08: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Live Attenuated Vaccines, 2015–2025
FIG 09: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Toxoid Vaccines, 2015–2025
FIG 10: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Recombinant Vaccines, 2015–2025
FIG 11: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Conjugate Vaccines, 2015–2025
FIG 12: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by DNA Vaccines, 2015–2025
FIG 13: Global Porcine Vaccines Market Attractiveness, by Technology, 2017–2025
FIG 14: Global Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 15: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diarrhea, 2015–2025
FIG 16: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Swine Influenza, 2015–2025
FIG 17: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Arthritis, 2015–2025
FIG 18: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Bordetella Rhinitis, 2015–2025
FIG 19: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PRRS, 2015–2025
FIG 20: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PCVAD, 2015–2025
FIG 21: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015–2025
FIG 22: Global Porcine Vaccines Market Attractiveness, by Disease Indication, 2017–2025
FIG 23: Global Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 24: Global Porcine Vaccines Market Attractiveness, by End-user, 2017–2025
FIG 25: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Veterinary Hospitals, 2015–2025
FIG 26: Global Porcine Vaccines Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hog Production Farms, 2015–2025
FIG 27: Global Porcine Vaccines Market Value Share, by Region, 2017 and 2025 
FIG 28: Global Porcine Vaccines Market Attractiveness, by Region, 2017–2025
FIG 29: North America Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 30: North America Porcine Vaccines Market Attractiveness, by Country, 2017–2025
FIG 31: North America Porcine Vaccines Market Value Share Analysis, by Country, 2017 and 2025
FIG 32: North America Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 33: North America Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 34: North America Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 35: North America Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 36: North America Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 37: North America Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 38: North America Swine Production Level, by Top Countries/States
FIG 39: Europe Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 40: Europe Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
FIG 41: Europe Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
FIG 41: Europe Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 43: Europe Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 44: Europe Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 45: Europe Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 46: Europe Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 47: Europe Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 48: Europe Swine Production Level, by Top Countries/States
FIG 49: Asia Pacific Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 50: Asia Pacific Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
FIG 51: Asia Pacific Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
FIG 52: Asia Pacific Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 53: Asia Pacific Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 54: Asia Pacific Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 55: Asia Pacific Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 56: Asia Pacific Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 57: Asia Pacific Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 58: Asia Pacific Swine Production Level, by Top Countries/States
FIG 59: Latin America Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 60: Latin America Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
FIG 61: Latin America Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
FIG 62: Latin America Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 63: Latin America Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 64: Latin America Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 65: Latin America Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 66: Latin America Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 67: Latin America Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 68: Latin America Swine Production Level, by Top Countries/States
FIG 69: Middle East & Africa Porcine Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG 70: Middle East & Africa Porcine Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
FIG 71: Middle East & Africa Porcine Vaccines Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
FIG 72: Middle East & Africa  Porcine Vaccines Market Value Share, by Technology, 2017 and 2025
FIG 73: Middle East & Africa  Porcine Vaccines Market Value Share, by Disease Indication, 2017 and 2025
FIG 74: Middle East & Africa  Porcine Vaccines Market Value Share, by End-user, 2017 and 2025
FIG 75: Middle East & Africa  Porcine Vaccines Market Attractiveness Analysis, by Technology, 2017–2025
FIG 76: Middle East & Africa  Porcine Vaccines Market Attractiveness Analysis, by Disease Indication, 2017–2025
FIG 77: Middle East & Africa  Porcine Vaccines Market Attractiveness Analysis, by End-user, 2017–2025
FIG 78: Global Porcine Vaccines Market Share Analysis, by Company, 2016

.